Back to search

France· FR:65130778

NIVAQUINE 100 mg, comprimé sécable

A chloroquine product containing sulfate de chloroquine, registered in France by SANOFI AVENTIS FRANCE, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC P01BA01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNIVAQUINE 100 mg, comprimé sécableATCP01BA01REGISTER NO.FR:65130778PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Chloroquine is registered in 7 of 19 countries.

Countries holding a registration under ATC P01BA01 (chloroquine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose

Chloroquine · ATC P01BA01

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of chloroquine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.

  • France: $1.22 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Chloroquine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • FR France$1.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SULFATE DE CHLOROQUINE
Manufacturer
SANOFI AVENTIS FRANCE
Country
France (FR)
ATC code
P01BA01
ATC class
Chloroquine
Defined daily dose
0.5 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930731000
    10 plaquette(s) PVC-Aluminium de 10 comprimé(s)
    EUR 4.55
  • cip13
    3400930731178
    2 plaquette(s) PVC-Aluminium de 10 comprimé(s)
    EUR 2.14

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

557 interactions on record for chloroquine.

Graded by severity as the source publishes them — 221 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chloroquine · interactions on record

557 records

  • 221 severe
  • 306 moderate
  • 14 minor
  • 16 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chloroquine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chloroquine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Cyprus · Chloroquine Phosphate Remedica
  • Spain · Resochín
  • United Kingdom (Northern Ireland) · Avloclor, Chloroquine Phosphate Bristol Laboratories
  • Greece · Unikinon
  • Hungary · Delagil
  • Netherlands · A-Cq 100
  • Portugal · Cloroquina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/23d3116c-3d4d-497f-903b-cff49bc814e4
GET /v1/drugs/23d3116c-3d4d-497f-903b-cff49bc814e4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65130778",
  "date_amm": "1998-01-30",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SULFATE DE CHLOROQUINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about chloroquine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.